Fluvac Innovator 5 (Canada)

Company: Zoetis

Encephalomyelitis-Rhinopneumonitis-Influenza Vaccine

Eastern & Western, Killed Virus

Tetanus Toxoid

Fluvac Innovator 5 Indications

For intramuscular vaccination of healthy horses 10 months of age or older as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses, equine rhinopneumonitis due to types 1 and 4 viruses, equine influenza due to type A2 viruses, and tetanus. Fluvac Innovator 5 contains equine influenza virus A/equine-2/Kentucky/97 (H3N8)-American Lineage. Efficacy has been demonstrated by challenge with equine influenza virus A/equine-2/Ohio/03 (H3N8)-American Lineage.

Dosage and Administration

Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.

Fluvac Innovator 5 Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

For Veterinary Use Only

Remove serial number and expiration date label and place on the animal’s medical chart.

U.S. Vet. License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

CPN: 1198430.2